Home/Gryphon Bio/Anthony DeLizza, MS

AD

Anthony DeLizza, MS

Chief Business Officer

Therapeutic Areas

Traumatic Brain Injury Alzheimer's Disease Mild Cognitive Impairment

Gryphon Bio Pipeline

Drug	Indication	Phase
Blood Biomarker Panel for TBI	Traumatic Brain Injury (Monitoring & Detection)	Clinical Studies
Blood Biomarker Panel for AD/MCI	Alzheimer's Disease / Mild Cognitive Impairment	Clinical Studies

Leadership Team at Gryphon Bio

Will Haskins, PhD

CEO & Co-Founder

Devin Jackson, PhD

Senior Research Scientist

Kristy Radeker, MSM

Associate Director, Clinical Operations & Finance

Research Associate

View full Gryphon Bio profile